Document is current
Any future updates will be listed below
-
Authors
Xiao, Yu https://orcid.org/0000-0002-8012-8121
Chen, Yan-Ming https://orcid.org/0000-0003-0783-5169
Zou, Zhongyu https://orcid.org/0000-0001-7152-5435
Ye, Chang https://orcid.org/0000-0003-0236-5671
Dou, Xiaoyang
Wu, Jinjun https://orcid.org/0000-0002-2379-1162
Liu, Chang https://orcid.org/0000-0001-5219-1089
Liu, Shun
Yan, Hao
Wang, Pingluan
Zeng, Tie-Bo https://orcid.org/0000-0002-8999-2952
Liu, Qinzhe https://orcid.org/0000-0002-3178-590X
Fei, Jingyi https://orcid.org/0000-0002-9775-3820
Tang, Weixin https://orcid.org/0000-0002-5739-5416
He, Chuan https://orcid.org/0000-0003-4319-7424
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (RM1 HG008935)
- License Information
-
More Information
Article History
Received: 5 March 2023
Accepted: 7 December 2023
First Online: 10 January 2024
Competing interests
: C.H. is a scientific founder, a member of the scientific advisory board and equity holder of Aferna Green, Inc. and AccuaDX Inc. and a scientific cofounder and equity holder of Accent Therapeutics. The remaining authors declare no competing interests.
